These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2908515)

  • 1. [Perspectives in the treatment of arterial hypertension: interventions at the dopaminergic system level].
    Soares-da-Silva P
    Rev Port Cardiol; 1988; 7(2):191-210. PubMed ID: 2908515
    [No Abstract]   [Full Text] [Related]  

  • 2. The dopaminergic system in hypertension.
    Zeng C; Zhang M; Asico LD; Eisner GM; Jose PA
    Clin Sci (Lond); 2007 Jun; 112(12):583-97. PubMed ID: 17492945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine action and metabolism in the kidney.
    Aperia A
    Curr Opin Nephrol Hypertens; 1994 Jan; 3(1):39-45. PubMed ID: 7850410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine, depression and antidepressants.
    Dailly E; Chenu F; Renard CE; Bourin M
    Fundam Clin Pharmacol; 2004 Dec; 18(6):601-7. PubMed ID: 15548230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysfunction of dopaminergic pathways in dystonia.
    Perlmutter JS; Mink JW
    Adv Neurol; 2004; 94():163-70. PubMed ID: 14509670
    [No Abstract]   [Full Text] [Related]  

  • 6. [The renal dopaminergic system and arterial hypertension].
    Pestana M; Guerra L
    Rev Port Cardiol; 1996 Dec; 15(12):893-902. PubMed ID: 9052965
    [No Abstract]   [Full Text] [Related]  

  • 7. Dopamine, the kidney and essential hypertension studies with gludopa.
    Lee MR
    Clin Exp Hypertens A; 1987; 9(5-6):977-86. PubMed ID: 3113781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Plasma dopamine beta-hydroxylase activity in hypertension treated with adrenergic beta receptor blockaders].
    Merkulova NK
    Ter Arkh; 1981; 53(1):69-72. PubMed ID: 7221913
    [No Abstract]   [Full Text] [Related]  

  • 9. [Adrenergic agents. Synthesis, secretion and metabolism. Implications in arterial hypertension].
    Peyrin L; Mornex R
    Rev Prat; 1980 Oct; 30(43):2907-8, 2911-2, 2915-6 passim. PubMed ID: 7003682
    [No Abstract]   [Full Text] [Related]  

  • 10. Results of treatment of hypertension after renal transplantation: effects of converting enzyme inhibitor, angiotensin II analog, beta-blockade, and dopamine beta-hydroxylase inhibitor.
    Ochiai T; Watanabe K; Nishijima H; Hayashi R; Sato H; Takagi T; Mikami K; Nishikawa T; Tamura Y; Kumagai A
    Transplant Proc; 1980 Sep; 12(3):520-5. PubMed ID: 6261430
    [No Abstract]   [Full Text] [Related]  

  • 11. Further characterization of the cardiovascular effects of the dopamine beta-hydroxylase inhibitor SK&F 102698 in conscious hypertensive rats.
    Ohlstein EH; Kruse LI; Ezekiel M; Willette RN
    J Pharmacol Exp Ther; 1988 Oct; 247(1):186-95. PubMed ID: 3050029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central dopamine function in affective illness: evidence from precursors, enzyme inhibitors, and studies of central dopamine turnover.
    Goodwin FK; Sack RL
    Adv Biochem Psychopharmacol; 1974; 12(0):261-79. PubMed ID: 4608958
    [No Abstract]   [Full Text] [Related]  

  • 13. [New inotropic agents in the treatment of congestive heart failure].
    Freitas M
    Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine involvement in the migraine attack.
    Fanciullacci M; Alessandri M; Del Rosso A
    Funct Neurol; 2000; 15 Suppl 3():171-81. PubMed ID: 11200788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presynaptic receptors for dopamine, histamine, and serotonin.
    Feuerstein TJ
    Handb Exp Pharmacol; 2008; (184):289-338. PubMed ID: 18064418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for dopamine-containing renal nerves.
    Dinerstein RJ; Jones RT; Goldberg LI
    Fed Proc; 1983 Oct; 42(13):3005-8. PubMed ID: 6617896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine and dopamine receptors as target sites for cardiovascular drug action.
    Berkowitz BA
    Fed Proc; 1983 Oct; 42(13):3019-21. PubMed ID: 6137421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medications for Parkinson's disease.
    Whitney CM
    Neurologist; 2007 Nov; 13(6):387-8. PubMed ID: 18090719
    [No Abstract]   [Full Text] [Related]  

  • 19. Dopa responsive dystonia and the Indian literature.
    Nair KR
    J Assoc Physicians India; 1995 Mar; 43(3):233-4. PubMed ID: 11256929
    [No Abstract]   [Full Text] [Related]  

  • 20. [Recessive dopa-responsive form of dystonia due to a mutation of the tyrosine hydroxylase gene].
    Rondot P; Wevers RA
    Bull Acad Natl Med; 1999; 183(3):639-46; discussion 646-7. PubMed ID: 10437291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.